Clinical Trial Update: Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a binary oncolytic adenovirus in combination with a HER2-specific autologous CAR-VST for advanced HER2-positive solid tumors; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Breast Cancer
• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer
• Head and Neck Squamous Cell Carcinoma
• Lung Cancer
• Salivary Gland Cancer

Drugs mentioned

• Binary Oncolytic Adenovirus
• HER2-specific autologous CAR VST

Snippet

Sponsor: Baylor College of Medicine | Conditions: Bladder Cancer, Head and Neck Squamous Cell Carcinoma | Phase 1 | Status: RECRUITING